VFA
ONC

Virtus Fund Advisers’s BeOne Medicines Ltd ONC Stock Holding History

Virtus Fund Advisers’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		$365K Buy
+3,733
New +$342K ﹤0.01% 383

Other funds holding ONC

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
HIM
Hillhouse Investment Management Grand Cayman, Cayman Islands $3.13B AUM 7.29% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return

Virtus Fund Advisers's ONC Position: Q4 2017 in Review

Virtus Fund Advisers opened a new position in BeOne Medicines Ltd (ONC) in Q4 2017: 3,733 shares worth $365K. The stake represents ﹤0.01% of the portfolio and ranks #383 among its holdings.

93 funds tracked by Wall St. Rank hold ONC as of Q4 2017.

  • Virtus Fund Advisers held 3,733 shares of BeOne Medicines Ltd worth $365K as of Q4 2017.
  • BeOne Medicines Ltd was a new Virtus Fund Advisers position in Q4 2017.
  • BeOne Medicines Ltd made up ﹤0.01% of Virtus Fund Advisers's portfolio in Q4 2017, its #383 holding.
  • 93 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q4 2017.

Based on Virtus Fund Advisers's 13F filing for Q4 2017, filed 9 Feb 2018.